Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Pinzani, P; Orlando, C; Raggi, CC; Distante, V; Valanzano, R; Tricarico, C; Maggi, M; Serio, M; Pazzagli, A
   Type-2 somatostatin receptor mRNA levels in breast and colon cancer determined by a quantitative RT-PCR assay based on dual label fluorogenic probe and the TaqMan (TM) technology
   REGULATORY PEPTIDES
   
   P. Pinzani et al., "Type-2 somatostatin receptor mRNA levels in breast and colon cancer determined by a quantitative RT-PCR assay based on dual label fluorogenic probe and the TaqMan (TM) technology", REGUL PEPT, 99(2-3), 2001, pp. 79-86
2. Orlando, C; Raggi, CC; Bagnoni, L; Sestini, R; Briganti, V; La Cava, G; Bernini, G; Tonini, G; Pazzagli, M; Serio, M; Maggi, M
   Somatostatin receptor type 2 gene expression in neuroblastoma, measured bycompetitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium-111-pentetreotide
   MEDICAL AND PEDIATRIC ONCOLOGY
   
   C. Orlando et al., "Somatostatin receptor type 2 gene expression in neuroblastoma, measured bycompetitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium-111-pentetreotide", MED PED ONC, 36(1), 2001, pp. 224-226
3. Zatelli, MC; Tagliati, F; Taylor, JE; Rossi, R; Culler, MD; degli Uberti, EC
   Somatostatin receptor subtypes 2 and 5 differentially affect proliferationin vitro of the human medullary thyroid carcinoma cell line TT
   JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
   
   M.C. Zatelli et al., "Somatostatin receptor subtypes 2 and 5 differentially affect proliferationin vitro of the human medullary thyroid carcinoma cell line TT", J CLIN END, 86(5), 2001, pp. 2161-2169
4. Bousquet, C; Puente, E; Buscail, L; Vaysse, N; Susini, C
   Antiproliferative effect of somatostatin and analogs
   CHEMOTHERAPY
   
   C. Bousquet et al., "Antiproliferative effect of somatostatin and analogs", CHEMOTHERA, 47, 2001, pp. 30-39
5. Ferjoux, G; Bousquet, C; Cordelier, P; Benali, N; Lopez, F; Rochaix, P; Buscail, L; Susini, C
   Signal transduction of somatostatin receptors negatively controlling cell proliferation
   JOURNAL OF PHYSIOLOGY-PARIS
   
   G. Ferjoux et al., "Signal transduction of somatostatin receptors negatively controlling cell proliferation", J PHYSL-PAR, 94(3-4), 2000, pp. 205-210
6. Dasgupta, P; Singh, AT; Mukherjee, R
   Lipophilization of somatostatin analog RC-160 with long chain fatty acid improves its anti-proliferative activity on human oral carcinoma cells in vitro.
   LIFE SCIENCES
   
   P. Dasgupta et al., "Lipophilization of somatostatin analog RC-160 with long chain fatty acid improves its anti-proliferative activity on human oral carcinoma cells in vitro.", LIFE SCI, 66(17), 2000, pp. 1557-1570
7. Halmos, G; Schally, AV; Sun, BD; Davis, R; Bostwick, DG; Plonowski, A
   High expression of somatostatin receptors and messenger ribonucleic acid for its receptor subtypes in organ-confined and locally advanced human prostate cancers
   JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
   
   G. Halmos et al., "High expression of somatostatin receptors and messenger ribonucleic acid for its receptor subtypes in organ-confined and locally advanced human prostate cancers", J CLIN END, 85(7), 2000, pp. 2564-2571
8. Halmos, G; Sun, BD; Schally, AV; Hebert, F; Nagy, A
   Human ovarian cancers express somatostatin receptors
   JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
   
   G. Halmos et al., "Human ovarian cancers express somatostatin receptors", J CLIN END, 85(10), 2000, pp. 3509-3512
9. Froidevaux, S; Heppeler, A; Eberle, AN; Meier, AM; Hausler, M; Beglinger, C; Behe, M; Powell, P; Macke, HR
   Preclinical comparison in AR4-2J tumor-bearing mice of four radiolabeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-somatostatin analogs for tumor diagnosis and internal radiotherapy
   ENDOCRINOLOGY
   
   S. Froidevaux et al., "Preclinical comparison in AR4-2J tumor-bearing mice of four radiolabeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-somatostatin analogs for tumor diagnosis and internal radiotherapy", ENDOCRINOL, 141(9), 2000, pp. 3304-3312
10. Dasgupta, P; Mukherjee, R
    Lipophilization of somatostatin analog RC-160 with long chain fatty acid improves its antiproliferative and antiangiogenic activity in vitro
    BRITISH JOURNAL OF PHARMACOLOGY
    
    P. Dasgupta e R. Mukherjee, "Lipophilization of somatostatin analog RC-160 with long chain fatty acid improves its antiproliferative and antiangiogenic activity in vitro", BR J PHARM, 129(1), 2000, pp. 101-109
11. Kimura, N; Pilichowska, M; Date, F; Kimura, I; Schindler, M
    Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors
    CLINICAL CANCER RESEARCH
    
    N. Kimura et al., "Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors", CLIN CANC R, 5(11), 1999, pp. 3483-3487
12. Tran, TA; Mattern, RH; Morgan, BA; Taylor, JE; Goodman, M
    Synthesis and binding potencies of cyclohexapeptide somatostatin analogs containing naphthylalanine and arylalkyl peptoid residues
    JOURNAL OF PEPTIDE SCIENCE
    
    T.A. Tran et al., "Synthesis and binding potencies of cyclohexapeptide somatostatin analogs containing naphthylalanine and arylalkyl peptoid residues", J PEPT SCI, 5(3), 1999, pp. 113-130
13. Papotti, M; Macri, L; Pagani, A; Aloi, F; Bussolati, G
    Quantitation of somatostatin receptor type 2 in neuroendocrine (Merkel cell) carcinoma of the skin by competitive RT-PCR
    ENDOCRINE PATHOLOGY
    
    M. Papotti et al., "Quantitation of somatostatin receptor type 2 in neuroendocrine (Merkel cell) carcinoma of the skin by competitive RT-PCR", ENDOCR PATH, 10(1), 1999, pp. 37-46
14. Florio, T; Thellung, S; Arena, S; Corsaro, A; Spaziante, R; Gussoni, G; Acuto, G; Giusti, M; Giordano, G; Schettini, G
    Somatostatin and its analog lanreotide inhibit the proliferation of dispersed human non-functioning pituitary adenoma cells in vitro
    EUROPEAN JOURNAL OF ENDOCRINOLOGY
    
    T. Florio et al., "Somatostatin and its analog lanreotide inhibit the proliferation of dispersed human non-functioning pituitary adenoma cells in vitro", EUR J ENDOC, 141(4), 1999, pp. 396-408
15. Held-Feindt, J; Krisch, B; Mentlein, R
    Molecular analysis of the somatostatin receptor subtype 2 in human glioma cells
    MOLECULAR BRAIN RESEARCH
    
    J. Held-Feindt et al., "Molecular analysis of the somatostatin receptor subtype 2 in human glioma cells", MOL BRAIN R, 64(1), 1999, pp. 101-107
16. Sellers, LA
    Prolonged activation of extracellular signal-regulated kinase by a proteinkinase C-dependent and N17Ras-insensitive mechanism mediates the proliferative response of G(i/o)-coupled somatostatin sst(4) receptors
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    L.A. Sellers, "Prolonged activation of extracellular signal-regulated kinase by a proteinkinase C-dependent and N17Ras-insensitive mechanism mediates the proliferative response of G(i/o)-coupled somatostatin sst(4) receptors", J BIOL CHEM, 274(34), 1999, pp. 24280-24288
17. Kahan, Z; Nagy, A; Schally, AV; Hebert, F; Sun, B; Groot, K; Halmos, C
    Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238
    INTERNATIONAL JOURNAL OF CANCER
    
    Z. Kahan et al., "Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238", INT J CANC, 82(4), 1999, pp. 592-598
18. Cattaneo, MG; Scita, G; Vicentini, LM
    Somatostatin inhibits PDGF-stimulated Ras activation in human neuroblastoma cells
    FEBS LETTERS
    
    M.G. Cattaneo et al., "Somatostatin inhibits PDGF-stimulated Ras activation in human neuroblastoma cells", FEBS LETTER, 459(1), 1999, pp. 64-68
19. ten Bokum, AMC; Hofland, LJ; de Jong, G; Bouma, J; Melief, MJ; Kwekkeboom, DJ; Schonbrunn, A; Mooy, CM; Laman, JD; Lamberts, SWJ; van Hagen, PM
    Immunohistochemical localization of somatostatin receptor sst(2A) in sarcoid granulomas
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    
    A.M.C. ten Bokum et al., "Immunohistochemical localization of somatostatin receptor sst(2A) in sarcoid granulomas", EUR J CL IN, 29(7), 1999, pp. 630-636
20. Abel, F; Ejeskar, K; Kogner, P; Martinsson, T
    Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2 (SSTR2) gene at 17q24
    BRITISH JOURNAL OF CANCER
    
    F. Abel et al., "Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2 (SSTR2) gene at 17q24", BR J CANC, 81(8), 1999, pp. 1402-1409
21. Fukuda, T; Yokoyama, N; Tamai, M; Imaizumi, M; Kimura, H; Tominaga, T; Ashizawa, K; Kiriyama, T; Yoshimine, H; Ohishi, K; Eguchi, K
    Thyrotropin secreting pituitary adenoma effectively treated with octreotide
    INTERNAL MEDICINE
    
    T. Fukuda et al., "Thyrotropin secreting pituitary adenoma effectively treated with octreotide", INTERN MED, 37(12), 1998, pp. 1027-1030
22. STOLZ B; WECKBECKER G; SMITHJONES PM; ALBERT R; RAULF F; BRUNS C
    THE SOMATOSTATIN RECEPTOR-TARGETED RADIOTHERAPEUTIC [Y-90-DOTA-DPHE(1),TYR(3)]OCTREOTIDE (Y-90-SMT-487) ERADICATES EXPERIMENTAL RAT PANCREATIC CA-20948 TUMORS
    European journal of nuclear medicine
    
    B. Stolz et al., "THE SOMATOSTATIN RECEPTOR-TARGETED RADIOTHERAPEUTIC [Y-90-DOTA-DPHE(1),TYR(3)]OCTREOTIDE (Y-90-SMT-487) ERADICATES EXPERIMENTAL RAT PANCREATIC CA-20948 TUMORS", European journal of nuclear medicine, 25(7), 1998, pp. 668-674
23. REISINGER I; BOHUSLAVITZKI KH; BRENNER W; BRAUNE S; DITTRICH I; GEIDE A; KETTNER B; OTTO HJ; SCHMIDT S; MUNZ DL
    SOMATOSTATIN RECEPTOR SCINTIGRAPHY IN SMALL-CELL LUNG-CANCER - RESULTS OF A MULTICENTER STUDY
    The Journal of nuclear medicine
    
    I. Reisinger et al., "SOMATOSTATIN RECEPTOR SCINTIGRAPHY IN SMALL-CELL LUNG-CANCER - RESULTS OF A MULTICENTER STUDY", The Journal of nuclear medicine, 39(2), 1998, pp. 224-227
24. SARRET P; BOTTO JM; VINCENT JP; MAZELLA J; BEAUDET A
    PREFERENTIAL EXPRESSION OF SST2A OVER SST2B SOMATOSTATIN RECEPTOR SPLICE VARIANT IN RAT-BRAIN AND PITUITARY
    Neuroendocrinology
    
    P. Sarret et al., "PREFERENTIAL EXPRESSION OF SST2A OVER SST2B SOMATOSTATIN RECEPTOR SPLICE VARIANT IN RAT-BRAIN AND PITUITARY", Neuroendocrinology, 68(1), 1998, pp. 37-43
25. MATO E; MATIASGUIU X; CHICO A; WEBB SM; CABEZAS R; BERNA L; DELEIVA A
    SOMATOSTATIN AND SOMATOSTATIN RECEPTOR SUBTYPE GENE-EXPRESSION IN MEDULLARY-THYROID CARCINOMA
    The Journal of clinical endocrinology and metabolism
    
    E. Mato et al., "SOMATOSTATIN AND SOMATOSTATIN RECEPTOR SUBTYPE GENE-EXPRESSION IN MEDULLARY-THYROID CARCINOMA", The Journal of clinical endocrinology and metabolism, 83(7), 1998, pp. 2417-2420
26. ROUSCH M; LUTGERINK JT; COOTE J; DEBRUINE A; ARENDS JW; HOOGENBOOM HR
    SOMATOSTATIN DISPLAYED ON FILAMENTOUS PHAGE AS A RECEPTOR-SPECIFIC AGONIST
    British Journal of Pharmacology
    
    M. Rousch et al., "SOMATOSTATIN DISPLAYED ON FILAMENTOUS PHAGE AS A RECEPTOR-SPECIFIC AGONIST", British Journal of Pharmacology, 125(1), 1998, pp. 5-16
27. REUBI JC; KAPPELER A; WASER B; LAISSUE J; HIPKIN RW; SCHONBRUNN A
    IMMUNOHISTOCHEMICAL LOCALIZATION OF SOMATOSTATIN RECEPTORS SST2A IN HUMAN TUMORS
    The American journal of pathology
    
    J.C. Reubi et al., "IMMUNOHISTOCHEMICAL LOCALIZATION OF SOMATOSTATIN RECEPTORS SST2A IN HUMAN TUMORS", The American journal of pathology, 153(1), 1998, pp. 233-245
28. DENT P; WANG YN; GU YZ; WOOD SL; REARDON DB; MANGUES R; PELLICER A; SCHONBRUNN A; STURGILL TW
    S49 CELLS ENDOGENOUSLY EXPRESS SUBTYPE-2 SOMATOSTATIN RECEPTORS WHICHCOUPLE TO INCREASE PROTEIN-TYROSINE-PHOSPHATASE ACTIVITY IN MEMBRANESAND DOWN-REGULATE RAF-1 ACTIVITY IN-SITU
    Cellular signalling
    
    P. Dent et al., "S49 CELLS ENDOGENOUSLY EXPRESS SUBTYPE-2 SOMATOSTATIN RECEPTORS WHICHCOUPLE TO INCREASE PROTEIN-TYROSINE-PHOSPHATASE ACTIVITY IN MEMBRANESAND DOWN-REGULATE RAF-1 ACTIVITY IN-SITU", Cellular signalling, 9(7), 1997, pp. 539-549
29. REARDON DB; DENT P; WOOD SL; KONG T; STURGILL TW
    ACTIVATION IN-VITRO OF SOMATOSTATIN RECEPTOR SUBTYPE-2, SUBTYPE-3, ORSUBTYPE-4 STIMULATES PROTEIN-TYROSINE-PHOSPHATASE ACTIVITY IN MEMBRANES FROM TRANSFECTED RAS-TRANSFORMED NIH 3T3 CELLS - COEXPRESSION WITH CATALYTICALLY INACTIVE SHP-2 BLOCKS RESPONSIVENESS
    Molecular endocrinology
    
    D.B. Reardon et al., "ACTIVATION IN-VITRO OF SOMATOSTATIN RECEPTOR SUBTYPE-2, SUBTYPE-3, ORSUBTYPE-4 STIMULATES PROTEIN-TYROSINE-PHOSPHATASE ACTIVITY IN MEMBRANES FROM TRANSFECTED RAS-TRANSFORMED NIH 3T3 CELLS - COEXPRESSION WITH CATALYTICALLY INACTIVE SHP-2 BLOCKS RESPONSIVENESS", Molecular endocrinology, 11(8), 1997, pp. 1062-1069
30. AIN KB; TAYLOR KD; TOFIQ S; VENKATARAMAN G
    SOMATOSTATIN RECEPTOR SUBTYPE EXPRESSION IN HUMAN THYROID AND THYROID-CARCINOMA CELL-LINES
    The Journal of clinical endocrinology and metabolism
    
    K.B. Ain et al., "SOMATOSTATIN RECEPTOR SUBTYPE EXPRESSION IN HUMAN THYROID AND THYROID-CARCINOMA CELL-LINES", The Journal of clinical endocrinology and metabolism, 82(6), 1997, pp. 1857-1862
31. SCHAER JC; WASER B; MENGOD G; REUBI JC
    SOMATOSTATIN RECEPTOR SUBTYPES SST(1), SST(2), SST(3) AND SST(5) EXPRESSION IN HUMAN PITUITARY, GASTROENTERO-PANCREATIC AND MAMMARY-TUMORS - COMPARISON OF MESSENGER-RNA ANALYSIS WITH RECEPTOR AUTORADIOGRAPHY
    International journal of cancer
    
    J.C. Schaer et al., "SOMATOSTATIN RECEPTOR SUBTYPES SST(1), SST(2), SST(3) AND SST(5) EXPRESSION IN HUMAN PITUITARY, GASTROENTERO-PANCREATIC AND MAMMARY-TUMORS - COMPARISON OF MESSENGER-RNA ANALYSIS WITH RECEPTOR AUTORADIOGRAPHY", International journal of cancer, 70(5), 1997, pp. 530-537
32. NILSSON L; FOLKESSON R
    COEXISTENCE OF SOMATOSTATIN RECEPTOR SUBTYPES IN THE HUMAN NEUROBLASTOMA CELL-LINE LA-N-2
    FEBS letters
    
    L. Nilsson e R. Folkesson, "COEXISTENCE OF SOMATOSTATIN RECEPTOR SUBTYPES IN THE HUMAN NEUROBLASTOMA CELL-LINE LA-N-2", FEBS letters, 401(1), 1997, pp. 83-88
33. KOENIG JA; EDWARDSON JM; HUMPHREY PPA
    SOMATOSTATIN RECEPTORS IN NEURO2A NEUROBLASTOMA-CELLS - OPERATIONAL CHARACTERISTICS
    British Journal of Pharmacology
    
    J.A. Koenig et al., "SOMATOSTATIN RECEPTORS IN NEURO2A NEUROBLASTOMA-CELLS - OPERATIONAL CHARACTERISTICS", British Journal of Pharmacology, 120(1), 1997, pp. 45-51
34. FEINDT J; MENTLEIN R; KRISCH B
    TIME-DEPENDENT INFLUENCE OF THE SOMATOSTATIN ANALOG OCTREOTIDE ON THEPROLIFERATION OF RAT ASTROCYTES AND GLIOMA-CELLS
    Brain research
    
    J. Feindt et al., "TIME-DEPENDENT INFLUENCE OF THE SOMATOSTATIN ANALOG OCTREOTIDE ON THEPROLIFERATION OF RAT ASTROCYTES AND GLIOMA-CELLS", Brain research, 746(1-2), 1997, pp. 309-313
35. SESTINI R; ORLANDO C; PERI A; TRICARICO C; PAZZAGLI M; SERIO M; PAGANI A; BUSSOLATI G; GRANCHI S; MAGGI M
    QUANTITATION OF SOMATOSTATIN RECEPTOR-TYPE-2 GENE-EXPRESSION IN NEUROBLASTOMA CELL-LINES AND PRIMARY TUMORS USING COMPETITIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION
    Clinical cancer research
    
    R. Sestini et al., "QUANTITATION OF SOMATOSTATIN RECEPTOR-TYPE-2 GENE-EXPRESSION IN NEUROBLASTOMA CELL-LINES AND PRIMARY TUMORS USING COMPETITIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION", Clinical cancer research, 2(10), 1996, pp. 1757-1765
36. SEDQI M; ROY S; MOHANRAJ D; RAMAKRISHNAN S; LOH HH
    ACTIVATION OF RAT THYMOCYTES SELECTIVELY UP-REGULATES THE EXPRESSION OF SOMATOSTATIN RECEPTOR SUBTYPE-1
    Biochemistry and molecular biology international
    
    M. Sedqi et al., "ACTIVATION OF RAT THYMOCYTES SELECTIVELY UP-REGULATES THE EXPRESSION OF SOMATOSTATIN RECEPTOR SUBTYPE-1", Biochemistry and molecular biology international, 38(1), 1996, pp. 103-112
37. TAYLOR JE; NELSON R; WOON CW
    REAL-TIME EVALUATION OF SOMATOSTATIN SUBTYPE-2 RECEPTOR ACTIVITY EMPLOYING THE TECHNIQUE OF CYTOSENSOR MICROPHYSIOMETRY
    Peptides
    
    J.E. Taylor et al., "REAL-TIME EVALUATION OF SOMATOSTATIN SUBTYPE-2 RECEPTOR ACTIVITY EMPLOYING THE TECHNIQUE OF CYTOSENSOR MICROPHYSIOMETRY", Peptides, 17(7), 1996, pp. 1257-1259
38. MCKEEN ES; FENIUK W; MICHEL AD; KIDD EJ; HUMPHREY PPA
    IDENTIFICATION AND CHARACTERIZATION OF HETEROGENEOUS SOMATOSTATIN BINDING-SITES IN RAT DISTAL COLONIC MUCOSA
    Naunyn-Schmiedeberg's archives of pharmacology
    
    E.S. Mckeen et al., "IDENTIFICATION AND CHARACTERIZATION OF HETEROGENEOUS SOMATOSTATIN BINDING-SITES IN RAT DISTAL COLONIC MUCOSA", Naunyn-Schmiedeberg's archives of pharmacology, 354(5), 1996, pp. 543-549
39. LIAPAKIS G; FITZPATRICK D; HOEGER C; RIVIER J; VANDLEN R; REISINE T
    IDENTIFICATION OF LIGAND-BINDING DETERMINANTS IN THE SOMATOSTATIN RECEPTOR SUBTYPE-1 AND SUBTYPE-2
    The Journal of biological chemistry
    
    G. Liapakis et al., "IDENTIFICATION OF LIGAND-BINDING DETERMINANTS IN THE SOMATOSTATIN RECEPTOR SUBTYPE-1 AND SUBTYPE-2", The Journal of biological chemistry, 271(34), 1996, pp. 20331-20339
40. WARHURST G; HIGGS NB; FAKHOURY H; WARHURST AC; GARDE J; COY DH
    SOMATOSTATIN RECEPTOR SUBTYPE-2 MEDIATES SOMATOSTATIN INHIBITION OF ION SECRETION IN RAT DISTAL COLON
    Gastroenterology
    
    G. Warhurst et al., "SOMATOSTATIN RECEPTOR SUBTYPE-2 MEDIATES SOMATOSTATIN INHIBITION OF ION SECRETION IN RAT DISTAL COLON", Gastroenterology, 111(2), 1996, pp. 325-333
41. VANETTI M; ZIOLKOWSKA B; WANG XM; HORN G; HOLLT V
    MESSENGER-RNA DISTRIBUTION OF 2 ISOFORMS OF SOMATOSTATIN RECEPTOR-2 (MSSTR2A AND MSSTR2B) IN MOUSE-BRAIN
    Molecular brain research
    
    M. Vanetti et al., "MESSENGER-RNA DISTRIBUTION OF 2 ISOFORMS OF SOMATOSTATIN RECEPTOR-2 (MSSTR2A AND MSSTR2B) IN MOUSE-BRAIN", Molecular brain research, 27(1), 1994, pp. 45-50
42. VANETTI M; ZIOLKOWSKA B; WANG XM; HORN G; HOLLT V
    MESSENGER-RNA DISTRIBUTION OF 2 ISOFORMS OF SOMATOSTATIN RECEPTOR-2 (MSSTR2A AND MSSTR2B) IN MOUSE-BRAIN
    Molecular brain research
    
    M. Vanetti et al., "MESSENGER-RNA DISTRIBUTION OF 2 ISOFORMS OF SOMATOSTATIN RECEPTOR-2 (MSSTR2A AND MSSTR2B) IN MOUSE-BRAIN", Molecular brain research, 27(1), 1994, pp. 45-50